Validation of the Turkish Swallowing Disturbance Questionnaire

NCT04737811 | Completed

• 1 other identifier: 440
• Study Type: observational
• Target: 152
• Locations: 1 country
• Sites: 1

Brief Summary

Purpose of the study is the validity and reliability of the Turkish version of the Swallowing Disturbance Questionnaire (SDQ-T), so that it would be used as an assessment tool for Turkish Parkinson Disease's (PD) patients. Despite being translated and validated in many languages, there is no validated Turkish version of SDQ to measure the severity of dysphagia in PD.

Conditions

Parkinson Disease; Dysphagia

Keywords

Parkinson's disease; dysphagia; questionnaire; swallowing; validation

Outcome Measures

Primary Outcomes (4)

• Turkish Version of Swallow Disturbance Questionnaire

  Turkish version of the questionnaire consists of 15 questions about dysphagia and swallowing complaints. The minimum score is 0 and maximum score is 44,5. The lower scores mean a normal swallowing function, higher scores mean worst swallowing functions.

  Baseline

• Turkish Version of Swallow Disturbance Questionnaire

  Turkish version of the questionnaire consists of 15 questions about dysphagia and swallowing complaints. The minimum score is 0 and maximum score is 44,5. The lower scores mean a normal swallowing function, higher scores mean worst swallowing functions.

  2 weeks

• Penetration and aspiration scale

  The scale consists of 8 levels for assessment of penetration and aspiration. The scores are from 0 to 8. Low score is better, higher score is worse.

  Baseline

• Yale Pharyngeal Residue Severity Rating Scale

  The scale consists of 5 assessment units and two localisations for pharyngeal residue. The scores are from 1 to 5 each localisation. Low score is better, higher score is worse.

  Baseline

Secondary Outcomes (1)

• Subject demographics

  Baseline

Study Arms (1)

Study group

The group consists of Parkinson's disease patients with dysphagia complaints. The participants will be given the Turkish version of the Swallow Disturbance Questionnaire (SDQ-T), which consisted of 15 questions and two scales evaluated with the fiberoptic endoscopic evaluation of swallowing. After two weeks, all participants will be given the SDQ-T for sampling.

Other: Turkish Version of Swallowing Disturbance Questionnaire

Interventions

Turkish Version of Swallowing Disturbance Questionnaire OTHER

The Turkish Version of Swallowing Disturbance Questionnaire consists of 15 questions related with dysphagia.

Study group

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Parkinson's disease patients

You may qualify if:

• Diagnosed with Parkinson's disease
• Able to speak, read, understand and write in Turkish
• Taking food orally
• Malignancy
• Having an active infection
• Advanced demans or

You may not qualify if:

• Diagnosed with other neurodegenerative disorders.
• Able not to speak, read, understand and write in Turkish
• Advanced demeans or other cognitive limitations
• Underwent any surgery last six months
• Pregnancy
• Underwent laryngectomy/neck dissection/tracheostomy/neck radiotherapy
• Out of age 18-80 years old.

Sponsors & Collaborators

• Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization: lead

Study Sites (1)

Prof Dr Cemil Tascioglu City Hospital

Istanbul, 34384, Turkey (Türkiye)

Location

Related Publications (2)

• Manor Y, Giladi N, Cohen A, Fliss DM, Cohen JT. Validation of a swallowing disturbance questionnaire for detecting dysphagia in patients with Parkinson's disease. Mov Disord. 2007 Oct 15;22(13):1917-21. doi: 10.1002/mds.21625.

  PMID: 17588237 BACKGROUND

• Cohen JT, Manor Y. Swallowing disturbance questionnaire for detecting dysphagia. Laryngoscope. 2011 Jul;121(7):1383-7. doi: 10.1002/lary.21839. Epub 2011 Jun 10.

  PMID: 21671239 BACKGROUND

MeSH Terms

Conditions

Parkinson Disease; Deglutition Disorders

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Esophageal Diseases; Gastrointestinal Diseases; Digestive System Diseases; Pharyngeal Diseases; Otorhinolaryngologic Diseases

Study Officials

• Yavuz Atar, Asso Prof,MD

  University of Health Sciences, ENT Clinic, Prof Dr Cemil Tascioglu City Hospital

  STUDY CHAIR

• Sevgi Atar, Special.,MD

  University of Health Sciences, PMR Clinic, Prof Dr Cemil Tascioglu City Hospital

  STUDY DIRECTOR

• Onur Akan, Special.,MD

  University of Health Sciences, Department of Neurology, Prof Dr Cemil Tascioglu City Hospital

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Specialist, MD

Study Record Dates

• First Submitted: January 30, 2021
• First Posted: February 4, 2021
• Study Start: December 7, 2020
• Primary Completion: March 7, 2021
• Study Completion: March 7, 2021
• Last Updated: August 3, 2021

Record last verified: 2021-07

Locations

TU (1)